已核实 DOI PubMed 相关产品: 73

High-level production of d-arabitol by Zygosaccharomyces rouxii from glucose: Metabolic engineering and process optimization

Journal 2022 · IF 11.889 · 发表于 2022 年 11 月 2 日
作者: Xiaolan Li,Yufei Zhang,Hossain M. Zabed,Junhua Yun,Guoyan Zhang,Mei Zhao,Yuvaraj Ravikumar,Xianghui Qi
阅读全文 在 PubMed 查看

摘要

d -Arabitol is a top value-added compound with wide applications in the food, pharmaceutical and biochemical industries. Nevertheless, sustainable biosynthesis of d -arabitol is limited by lack of efficient strains and suitable fermentation process. Herein, metabolic engineering and process optimization were performed in Zygosaccharomyces rouxii to overcoming these limitations. Adopting systems metabolic engineering include enhancement of innate biosynthetic pathway, supply of precursor substrate d -ribulose-5P and cofactors regeneration, a novel recombinant strain ZR-5A with good performance was obtained, which boosted d -arabitol production up to 29.01 g/L, 59.31 % higher than the parent strain. Further with the optimum medium composition and fed-batch fermentation, the strain ZR-5A finally produced 149.10 g/L d -arabitol with the productivity of 1.04 g/L/h, which was the highest titer ever reported by Z.rouxii system. This is the first report on the use of metabolic engineering to construct Z. rouxii chassis for the sustainable production of d -arabitol.

本研究中使用的阿拉丁产品

73 款产品在本文中被引用